Yazawa R, Ishida M, Balavarca Y, Hennige AM, et al. A randomized Phase I study of the safety, tolerability, pharmacokinetics and pharmacodynamics of BI 456906, a dual glucagon receptor/glucagon-like peptide-1 receptor agonist, in healthy Japanese men with overweight/obesity. Diabetes Obes Metab 2023;25:1973-1984.
PMID: 36974349